Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-25 Sale |
2021-06-29 5:23 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary |
473,250 | $30.83 | $14,589,493 | 8,558,707 (Indirect Direct) |
View |
| 2021-06-25 Sale |
2021-06-29 5:23 pm |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
473,250 | $30.83 | $14,589,493 | 8,546,750 (Indirect) |
View |
| 2021-06-25 Sale |
2021-06-29 5:22 pm |
BioXcel Therapeutics Inc. | BTAI | BioXcel LLC 10% Owner |
473,250 | $30.83 | $14,589,493 | 8,546,750 (Direct) |
View |
| 2021-06-25 Sale |
2021-06-29 5:21 pm |
BioXcel Therapeutics Inc. | BTAI | BioXcel Holdings Inc. 10% Owner |
473,250 | $30.83 | $14,589,493 | 8,546,750 (Indirect) |
View |
| 2021-03-15 Sale |
2021-03-17 5:00 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $48.5 | $727,573 | 58,397 (Direct) |
View |
| 2021-02-17 Sale |
2021-02-19 7:35 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $55.58 | $1,389,459 | 80,472 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 4:56 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $57.68 | $865,153 | 73,397 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 4:15 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $48.15 | $180,563 | 81,648 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 4:25 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $48.39 | $725,814 | 142,707 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-14 Option Award |
2022-05-17 3:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-05-14 Option Award |
2022-05-17 3:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Senior VP and CFO |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-05-14 Option Award |
2022-05-17 3:38 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 4:20 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
8,337 | $0 | 8,337 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 4:18 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
41,687 | $0 | 41,687 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 4:17 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
208,750 | $0 | 208,750 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 4:16 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
41,687 | $0 | 41,687 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
41,687 | $0 | 41,687 (Direct) |
View |
Ownership |
2022-02-14 5:38 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
0 | $0 | 8,558,707 (Indirect) |
View |
| 2021-04-06 Ownership |
2022-02-14 5:38 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
233,227 | $0 | 8,558,707 (Indirect) |
View |
| 2021-04-06 Ownership |
2022-02-14 5:37 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
233,227 | $0 | 8,546,750 (Indirect) |
View |
| 2022-01-17 Option Award |
2022-01-19 4:19 pm |
N/A 2032-01-16 |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 5:27 pm |
N/A 2031-08-16 |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 5:25 pm |
N/A 2031-08-16 |
BioXcel Therapeutics Inc. | BTAI | Kane William P Jr Chief Commercial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-11 Other |
2021-06-15 5:36 pm |
N/A 2031-06-11 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
14,500 | $0 | 14,500 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:36 pm |
N/A 2031-06-11 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
14,500 | $0 | 14,500 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:34 pm |
N/A 2031-06-11 |
BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director |
14,500 | $0 | 14,500 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:33 pm |
N/A 2031-06-11 |
BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director |
14,500 | $0 | 14,500 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:32 pm |
N/A 2031-06-11 |
BioXcel Therapeutics Inc. | BTAI | Bray June Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 8:53 pm |
N/A 2031-03-25 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 8:49 pm |
N/A 2031-03-25 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 8:45 pm |
N/A 2031-03-25 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 8:42 pm |
N/A 2031-03-25 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary |
250,000 | $0 | 250,000 (Direct) |
View |
| 2020-07-24 Other |
2021-03-18 8:21 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | BioXcel Holdings Inc. 10% Owner |
160,000 | $60.76 | 9,500,000 (Indirect) |
View |
| 2020-07-24 Other |
2021-03-18 8:20 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | BioXcel LLC 10% Owner |
160,000 | $60.76 | 9,180,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 7:01 pm |
N/A 2021-03-01 |
BioXcel Therapeutics Inc. | BTAI | Bray June Director |
4,167 | $0 | 4,167 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 6:59 pm |
N/A 2031-02-21 |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-19 7:35 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
10,000 | $11 | 80,472 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-19 7:35 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0 | 80,472 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-19 7:35 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
15,000 | $0.41 | 80,472 (Direct) |
View |
| 2020-07-24 Ownership |
2021-02-16 5:29 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary |
265,150 | $0 | 9,020,000 (Direct) |
View |
Ownership |
2021-02-16 5:28 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
0 | $0 | 9,021,000 (Indirect) |
View |
| 2020-07-24 Ownership |
2021-02-16 5:28 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
265,150 | $0 | 9,021,000 (Direct) |
View |
| 2019-04-01 Gift |
2021-02-16 5:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
1,000 | $0 | 9,340,000 (Direct) |
View |
| 2020-07-24 Other |
2021-02-16 5:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
240,000 | $60.76 | 9,340,000 (Indirect) |
View |
| 2021-02-01 Exercise |
2021-02-03 4:15 pm |
N/A 2027-10-02 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $0 | 81,648 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $5.55 | 81,648 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 4:25 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $0 | 142,707 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 4:25 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $0.41 | 142,707 (Direct) |
View |